Alector, Inc. (ALEC)
2.47
-0.25
(-9.19%)
USD |
NASDAQ |
Sep 03, 15:05
Alector Max Drawdown (5Y) : 97.71% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 97.71% |
| July 31, 2026 | 97.71% |
| June 30, 2026 | 97.71% |
| May 31, 2026 | 97.71% |
| April 30, 2026 | 97.71% |
| March 31, 2026 | 97.71% |
| February 28, 2026 | 97.71% |
| January 31, 2026 | 97.71% |
| December 31, 2025 | 97.71% |
| November 30, 2025 | 97.71% |
| October 31, 2025 | 97.71% |
| September 30, 2025 | 97.71% |
| August 31, 2025 | 97.71% |
| July 31, 2025 | 97.71% |
| June 30, 2025 | 97.71% |
| May 31, 2025 | 97.71% |
| April 30, 2025 | 97.71% |
| March 31, 2025 | 96.89% |
| February 28, 2025 | 95.92% |
| January 31, 2025 | 95.86% |
| December 31, 2024 | 95.64% |
| November 30, 2024 | 93.56% |
| October 31, 2024 | 90.45% |
| September 30, 2024 | 90.45% |
| August 31, 2024 | 90.45% |
| Date | Value |
|---|---|
| July 31, 2024 | 90.45% |
| June 30, 2024 | 90.45% |
| May 31, 2024 | 90.45% |
| April 30, 2024 | 90.45% |
| March 31, 2024 | 90.45% |
| February 29, 2024 | 90.45% |
| January 31, 2024 | 90.45% |
| December 31, 2023 | 90.45% |
| November 30, 2023 | 90.45% |
| October 31, 2023 | 87.03% |
| September 30, 2023 | 86.84% |
| August 31, 2023 | 86.20% |
| July 31, 2023 | 85.19% |
| June 30, 2023 | 85.19% |
| May 31, 2023 | 85.19% |
| April 30, 2023 | 85.19% |
| March 31, 2023 | 85.19% |
| February 28, 2023 | 82.58% |
| January 31, 2023 | 82.58% |
| December 31, 2022 | 82.58% |
| November 30, 2022 | 82.58% |
| October 31, 2022 | 80.63% |
| September 30, 2022 | 80.63% |
| August 31, 2022 | 80.63% |
| July 31, 2022 | 80.63% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Oncolytics Biotech, Inc. | 92.83% |
| Sangamo Therapeutics, Inc. | 99.68% |
| Sarepta Therapeutics, Inc. | 93.33% |
| Anixa Biosciences, Inc. | 70.17% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -48.73 |
| Beta (5Y) | 0.6487 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 79.18% |
| Historical Sharpe Ratio (5Y) | -0.5411 |
| Historical Sortino (5Y) | -0.9308 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.95% |